ABSTRACT
BACKGROUND: Around 10-15% of the in-patient population carry unsubstantiated 'penicillin allergy' labels, the majority incorrect when tested. These labels are associated with harm from use of broad-spectrum non-penicillin antibiotics. Current testing guidelines incorporate both skin and challenge tests; this is prohibitively expensive and time-consuming to deliver on a large scale. We aimed to establish the feasibility of a rapid access de-labelling pathway for surgical patients, using direct oral challenge. METHODS: 'Penicillin allergic' patients, recruited from a surgical pre-assessment clinic, were risk-stratified using a screening questionnaire. Patients at low risk of true, immunoglobulin E (IgE)-mediated allergy were offered direct oral challenge using incremental amoxicillin to a total dose of 500 mg. A 3-day course was completed at home. De-labelled patients were followed up to determine antibiotic use in surgery, and attitudes towards de-labelling were explored. RESULTS: Of 219 patients screened, 74 were eligible for inclusion and offered testing. We subsequently tested 56 patients; 55 were de-labelled. None had a serious reaction to the supervised challenge, or thereafter. On follow-up, 17 of 19 patients received appropriate antimicrobial prophylaxis during surgery. Only three of 33 de-labelled patients would have been happy for the label to be removed without prior specialist testing. CONCLUSION: Rapid access de-labelling, using direct oral challenge in appropriately risk-stratified patients, can be incorporated into the existing surgical care pathway. This provides immediate and potential long-term benefit for patients. Interest in testing is high among patients, and clinicians appear to follow clinic recommendations. Patients are unlikely to accept removal of their allergy label on the basis of history alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: AN17/92982.
Subject(s)
Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Drug Hypersensitivity/diagnosis , Elective Surgical Procedures , Penicillins/administration & dosage , Preoperative Care/methods , Feasibility Studies , Humans , United KingdomABSTRACT
The FKBP5 gene product forms part of a complex with the glucocorticoid receptor and can modulate cortisol-binding affinity. Variations in the gene have been associated with increased recurrence of depression and with rapid response to antidepressant treatment. We sought to determine whether common FKBP5 variants confer risk for bipolar disorder. We genotyped seven tag single-nucleotide polymorphisms (SNPs) in FKBP5, plus two SNPs previously associated with illness, in 317 families with 554 bipolar offspring, derived primarily from two studies. Single marker and haplotypic analyses were carried out with FBAT and EATDT employing the standard bipolar phenotype. Association analyses were also conducted using 11 disease-related variables as covariates. Under an additive genetic model, rs4713902 showed significant overtransmission of the major allele (P=0.0001), which was consistent across the two sample sets (P=0.004 and 0.006). rs7757037 showed evidence of association that was strongest under the dominant model (P=0.001). This result was consistent across the two datasets (P=0.017 and 0.019). The dominant model yielded modest evidence for association (P<0.05) for three additional markers. Covariate-based analyses suggested that genetic variation within FKBP5 may influence attempted suicide and number of depressive episodes in bipolar subjects. Our results are consistent with the well-established relationship between the hypothalamic-pituitary-adrenal (HPA) axis, which mediates the stress response through regulation of cortisol, and mood disorders. Ongoing whole-genome association studies in bipolar disorder and major depression should further clarify the role of FKBP5 and other HPA genes in these illnesses.
Subject(s)
Bipolar Disorder/genetics , Genetic Predisposition to Disease , Tacrolimus Binding Proteins/genetics , Bipolar Disorder/physiopathology , Cohort Studies , Haplotypes , Humans , Hypothalamo-Hypophyseal System/physiopathology , Linkage Disequilibrium , Mood Disorders/genetics , Mood Disorders/physiopathology , Pedigree , Pituitary-Adrenal System/physiopathology , Polymorphism, Single NucleotideSubject(s)
Adjustment Disorders/therapy , Child Behavior Disorders/therapy , Psychoanalytic Therapy/methods , Psychosexual Development , Schizophrenia/therapy , Adjustment Disorders/psychology , Adolescent , Child Behavior Disorders/psychology , Countertransference , Ego , Female , Humans , Male , Patient Acceptance of Health Care , Personality Development , Psychoanalytic Theory , Schizophrenic PsychologyABSTRACT
The author notes that childhood depression has become an accepted diagnostic entity, an affective disorder related to unipolar and bipolar illnesses. He indicates the importance of trying to distinguish between depression as a symptom and depression as a syndrome. Clinicians treating depressed children need to keep abreast of contemporary research on the role of metabolic dysfunctions in depression.
Subject(s)
Depressive Disorder/psychology , Suicide/psychology , Adolescent , Age Factors , Bipolar Disorder/psychology , Child , Child Behavior Disorders/psychology , Child Development , Depressive Disorder/diagnosis , Diagnosis, Differential , Female , Humans , Male , Psychotherapy , Suicide PreventionABSTRACT
The author postulates that depression exists in adolescents, with the level of ego development producing varying clinical pictures. Therapy is based upon the psychoanalytic theory of personality development. Individual treatment is based on age and intelligence of patient, level of ego development, defenses utilized, attitude of parents, and community facilities available.
Subject(s)
Depression/therapy , Suicide Prevention , Adjustment Disorders/therapy , Adolescent , Anorexia Nervosa/therapy , Child , Child, Preschool , Defense Mechanisms , Ego , Female , Humans , Intelligence , Learning Disabilities/therapy , Male , Parent-Child Relations , Personality Development , Psychophysiologic Disorders/therapy , PsychotherapyABSTRACT
Suicide figures are generally underestimated, more so for children and adolescents than for adults. Yet suicide among adolescents has shown the greates rise for any age group. Every youngster who attempts or threatens suicide should have a thorough psychiatric evaluation. Most of them require intense therapy, either individually or in a group.
